Can an mRNA Shot Help Fight Lung Cancer? University of Florida Trial Is Recruiting

SupaJamz News | Florida Health Report | November 10, 2026

GAINESVILLE, Fla. — Could a shot designed for COVID-19 help an existing lung cancer treatment work better? The University of Florida is recruiting adults with stage 4 non-small cell lung cancer to find out. The Nov. 2 update to the trial listing shows the Gainesville site is recruiting for a Phase 2 study called UNIFIER, which aims to enroll 500 adults. Nov. 2 recruitment update

What Florida researchers are testing now

The study compares people who get the Pfizer-BioNTech mRNA COVID-19 vaccine before starting pembrolizumab and chemotherapy with people who start the same cancer treatment without getting the shot beforehand. Pembrolizumab is an immunotherapy drug that helps the immune system attack cancer. The trial’s main measure is how often immune-related side effects require hospitalization within 60 days. The team will also track how long participants live without their cancer worsening. Trial design and outcomes

The bigger idea behind a cancer vaccine

In July 2025, a team led by UF Health pediatric oncologist Dr. Elias Sayour reported that an experimental mRNA vaccine helped immunotherapy fight tumors in mice. The researchers designed the shot to rally the immune system without targeting a particular tumor protein. That approach raises the possibility of an off-the-shelf treatment that could one day be tested across different cancers. UF’s experimental formulation and the Pfizer-BioNTech shot in the lung cancer trial are different vaccines. The trial could help guide the development of a future cancer vaccine. Trial research background · July 2025 study in Nature Biomedical Engineering

Later that year, researchers at UF and the University of Texas MD Anderson Cancer Center looked back at patient records. They found that people with advanced non-small cell lung cancer or melanoma who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy tended to live longer. That study found a link. A randomized comparison gives researchers a better way to find out whether adding the shot makes a difference. October 2025 study in Nature

What families should take away

The Gainesville trial is about helping treatment work better for people who already have a specific type of lung cancer. A universal cancer vaccine remains a research goal, and the Phase 2 trial has yet to report results. Patients and families can find the study’s eligibility rules and contact information under trial ID NCT07597070. Official trial record